IBDEI06N ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2911,1,4,0)
 ;;=4^Cancer, Upper Inner Breast
 ;;^UTILITY(U,$J,358.3,2911,1,5,0)
 ;;=5^174.2
 ;;^UTILITY(U,$J,358.3,2911,2)
 ;;=Cancer, Upper Inner Breast^267196
 ;;^UTILITY(U,$J,358.3,2912,0)
 ;;=174.4^^26^239^12
 ;;^UTILITY(U,$J,358.3,2912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2912,1,4,0)
 ;;=4^Cancer, Upper Outer Breast
 ;;^UTILITY(U,$J,358.3,2912,1,5,0)
 ;;=5^174.4
 ;;^UTILITY(U,$J,358.3,2912,2)
 ;;=Cancer, Upper Outer Breast^267198
 ;;^UTILITY(U,$J,358.3,2913,0)
 ;;=610.0^^26^239^13
 ;;^UTILITY(U,$J,358.3,2913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2913,1,4,0)
 ;;=4^Cyst,Breast
 ;;^UTILITY(U,$J,358.3,2913,1,5,0)
 ;;=5^610.0
 ;;^UTILITY(U,$J,358.3,2913,2)
 ;;=^112247
 ;;^UTILITY(U,$J,358.3,2914,0)
 ;;=625.3^^26^239^14
 ;;^UTILITY(U,$J,358.3,2914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2914,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,2914,1,5,0)
 ;;=5^625.3
 ;;^UTILITY(U,$J,358.3,2914,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,2915,0)
 ;;=610.1^^26^239^18
 ;;^UTILITY(U,$J,358.3,2915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2915,1,4,0)
 ;;=4^Fibrocystic Disease,Breast
 ;;^UTILITY(U,$J,358.3,2915,1,5,0)
 ;;=5^610.1
 ;;^UTILITY(U,$J,358.3,2915,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,2916,0)
 ;;=217.^^26^239^2
 ;;^UTILITY(U,$J,358.3,2916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2916,1,4,0)
 ;;=4^Benign Neoplasm Breast
 ;;^UTILITY(U,$J,358.3,2916,1,5,0)
 ;;=5^217.
 ;;^UTILITY(U,$J,358.3,2916,2)
 ;;=^267638
 ;;^UTILITY(U,$J,358.3,2917,0)
 ;;=617.9^^26^239^15
 ;;^UTILITY(U,$J,358.3,2917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2917,1,4,0)
 ;;=4^Endometriosis
 ;;^UTILITY(U,$J,358.3,2917,1,5,0)
 ;;=5^617.9
 ;;^UTILITY(U,$J,358.3,2917,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,2918,0)
 ;;=618.6^^26^239^16
 ;;^UTILITY(U,$J,358.3,2918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2918,1,4,0)
 ;;=4^Enterocele,Vaginal
 ;;^UTILITY(U,$J,358.3,2918,1,5,0)
 ;;=5^618.6
 ;;^UTILITY(U,$J,358.3,2918,2)
 ;;=^56796
 ;;^UTILITY(U,$J,358.3,2919,0)
 ;;=625.6^^26^239^20
 ;;^UTILITY(U,$J,358.3,2919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2919,1,4,0)
 ;;=4^Incontin,Female Stress
 ;;^UTILITY(U,$J,358.3,2919,1,5,0)
 ;;=5^625.6
 ;;^UTILITY(U,$J,358.3,2919,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,2920,0)
 ;;=611.72^^26^239^21
 ;;^UTILITY(U,$J,358.3,2920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2920,1,4,0)
 ;;=4^Lump/Mass In Breast
 ;;^UTILITY(U,$J,358.3,2920,1,5,0)
 ;;=5^611.72
 ;;^UTILITY(U,$J,358.3,2920,2)
 ;;=Lump/Mass in Breast^72018
 ;;^UTILITY(U,$J,358.3,2921,0)
 ;;=795.00^^26^239^1
 ;;^UTILITY(U,$J,358.3,2921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2921,1,4,0)
 ;;=4^Abnormal Pap Smear, Nos
 ;;^UTILITY(U,$J,358.3,2921,1,5,0)
 ;;=5^795.00
 ;;^UTILITY(U,$J,358.3,2921,2)
 ;;=Abnormal Pap Smear, NOS^117041
 ;;^UTILITY(U,$J,358.3,2922,0)
 ;;=618.00^^26^239^29
 ;;^UTILITY(U,$J,358.3,2922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2922,1,4,0)
 ;;=4^Vaginal Wall Prolpse Nos
 ;;^UTILITY(U,$J,358.3,2922,1,5,0)
 ;;=5^618.00
 ;;^UTILITY(U,$J,358.3,2922,2)
 ;;=^331533
 ;;^UTILITY(U,$J,358.3,2923,0)
 ;;=611.89^^26^239^19
 ;;^UTILITY(U,$J,358.3,2923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2923,1,4,0)
 ;;=4^Hematoma,Breast
 ;;^UTILITY(U,$J,358.3,2923,1,5,0)
 ;;=5^611.89
 ;;^UTILITY(U,$J,358.3,2923,2)
 ;;=^336616
 ;;^UTILITY(U,$J,358.3,2924,0)
 ;;=173.51^^26^239^10
 ;;^UTILITY(U,$J,358.3,2924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2924,1,4,0)
 ;;=4^Cancer, Skin Of Breast
 ;;^UTILITY(U,$J,358.3,2924,1,5,0)
 ;;=5^173.51
 ;;^UTILITY(U,$J,358.3,2924,2)
 ;;=^340479
